Status:
WITHDRAWN
The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Psoriasis
Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect that weight loss has on the severity of psoriasis in obese subjects. Fifty obese (BMI equal to or greater than 30) patients with moderate to severe ...
Eligibility Criteria
Inclusion
- \>18 years of age
- A Body Mass Index (BMI) \>/= 30
- Subject has plaque psoriasis
- A Psoriasis Area Severity Index (PASI) score \>/= 10 or a total body surface area (BSA) affected by psoriasis \>/= 10%
- Capable of reading, understanding, and signing a consent form
- Females of childbearing potential must have negative urine pregnancy test on Day 0, and agree to a medically effective method of birth control (as determined by the investigator)
Exclusion
- Already participating in a study for weight loss or a study of other psoriasis treatments
- If they are on systemic therapy for their psoriasis
- Female subjects who are pregnant or planning to become pregnant
- Patients with a history of anorexia nervosa, bulimia, or other diseases that would make a weight loss program a risk to their health
- Subjects unable to comply with study protocol
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01137448
Start Date
June 1 2010
End Date
May 1 2013
Last Update
December 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Dermatology Clinical Research
Houston, Texas, United States, 77030